Completed EARLY_PHASE1 INTERVENTIONAL 1-arm NCT02363478

Long Term Effect of Buspirone on Esophageal Function and Esophageal Symptoms in Patients With Systematic Sclerosis (SSc)

Sponsor: Laikο General Hospital, Athens

Interventions buspirone

Updated 7 times since 2017 Last updated: Aug 31, 2016 Started: Dec 31, 2014 Primary completion: Sep 30, 2015 Completion: Sep 30, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This EARLY_PHASE1 trial investigates Systemic Sclerosis and is currently completed. Laikο General Hospital, Athens leads this study, which shows 7 recorded versions since 2014 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed EARLY_PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed EARLY_PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed EARLY_PHASE1
Jul 2019 — Jan 2021 [monthly]

Completed EARLY_PHASE1
Jun 2018 — Jul 2019 [monthly]

Completed EARLY_PHASE1

▶ Show 2 earlier versions

Feb 2017 — Jun 2018 [monthly]

Completed EARLY_PHASE1

Phase: Phase 0 → EARLY_PHASE1
Jan 2017 — Feb 2017 [monthly]

Completed Phase 0

First recorded

Dec 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Laikο General Hospital, Athens

Data source: Laikο General Hospital, Athens

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Athens, Greece